Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

14.09.2026

1 Ann Nucl Med
36 Clin Nucl Med
2 J Cereb Blood Flow Metab
1 J Nucl Cardiol
15 J Nucl Med
1 Lancet Neurol
5 Nucl Med Commun
5 Phys Med Biol
1 PLoS One
1 Semin Nucl Med


    Ann Nucl Med

  1. SERFLING SE, Zhi Y, Higuchi T, Hartrampf PE, et al
    Procedure-related uptake on CXCR4 PET/CT: a frequent pitfall independent of time and anatomical site.
    Ann Nucl Med. 2026 Sep 5. doi: 10.1007/s12149-026-02276.
    >> Share


    Clin Nucl Med

  2. ROSOK D, Hautzel H, Bertram S, Umutlu L, et al
    Somatostatin Receptor-Expressing Hibernoma Mimicking Malignancy on SSTR-PET in MEN1: A Diagnostic Pitfall.
    Clin Nucl Med. 2026 Sep 8. doi: 10.1097/RLU.0000000000006688.
    >> Share

  3. RABANI F, Elahifard H, Tanha AS, Bari A, et al
    Diagnostic Superiority of 68Ga-FAPI PET/CT Over 18F-FDG in Restaging of Advanced Epithelioid Sarcoma.
    Clin Nucl Med. 2026 Sep 8. doi: 10.1097/RLU.0000000000006685.
    >> Share

  4. MOK A, Chen J, Russon A, Mansberg V, et al
    Incidental Glioblastoma Multiforme Detected on 18F-DCFPyL PET/CT Prostate Cancer Staging.
    Clin Nucl Med. 2026 Sep 8. doi: 10.1097/RLU.0000000000006697.
    >> Share

  5. KAVALDAR A, Singh D, Kumar P, Jain S, et al
    Complete Pachydermoperiostosis With Acromegaloid Phenotype: Characteristic 99m Tc-Methylene Diphosphonate (MDP) Skeletal Scintigraphy in a Rare Clinical Mimic of Acromegaly.
    Clin Nucl Med. 2026;51:e972-e974.
    >> Share

  6. ZHANG Z, Wang H, Zhuang H, Li F, et al
    Partial Remission in Pediatric Relapsed Neuroblastoma After Multiple Cycle Low-Dose 211 At-MABG Therapy.
    Clin Nucl Med. 2026;51:947-949.
    >> Share

  7. SRINIVASAN P, Kumar SA, Goyal H, Halanaik D, et al
    Multifocal Hepatic Epstein-Barr Virus-Associated Smooth Muscle Tumor Mimicking Posttransplant Lymphoproliferative Disorder in a Renal Allograft Recipient.
    Clin Nucl Med. 2026;51:e962-e963.
    >> Share

  8. MOU L, Liu Y, Yang H, Zheng W, et al
    Combined 177Lu-FAP-2286 Therapy and Immunotherapy in Metastatic Esophageal Squamous Cell Carcinoma.
    Clin Nucl Med. 2026 Jul 28. doi: 10.1097/RLU.0000000000006591.
    >> Share

  9. JIN Z, Kong W, Sun T, Tu J, et al
    Primary Seminoma Arising in the Superior Vena Cava.
    Clin Nucl Med. 2026;51:936-937.
    >> Share

  10. FENG L, Liu W, Zhao YX, Chan KW, et al
    Caudate-Predominant Striatal Dopaminergic Deficit Distinguishes Behavioral Variant of Frontotemporal Dementia With Parkinsonism From Other Parkinsonian Syndromes.
    Clin Nucl Med. 2026;51:e886-e893.
    >> Share

  11. FAKKERT RK, van Nierop BJ, van Rooij R, Lam MGEH, et al
    Rapid Lymphatic Clearance After Subcutaneous Extravasation of 177 Lu-PSMA-I&T Radioligand Therapy.
    Clin Nucl Med. 2026;51:e955-e956.
    >> Share

  12. YU C, Chen X, Wang K, Liu Y, et al
    177 Lu-FAP-2286 Therapy in a Patient of Advanced Metastatic Malignant Solitary Fibrous Tumor.
    Clin Nucl Med. 2026;51:894-895.
    >> Share

  13. MAS PASCASIO C, Ruiz de Almiron de Andres B, Lopez Rodriguez E, Sanz Viedma S, et al
    Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.
    Clin Nucl Med. 2026;51:e953-e954.
    >> Share

  14. WANG X, Zhang B, Zhang K, Lv C, et al
    18 F-MFBG Uptake From Multiple Focal "Hot Spots" to Superscan in a Pediatric Patient With High-risk Neuroblastoma.
    Clin Nucl Med. 2026;51:891-893.
    >> Share

  15. SABER TANHA A, Askari E, Moeini Nodeh M, Aghaee A, et al
    99mTc?FAPI?46 Scintigraphy for Staging of Non-Small Cell Lung Carcinoma.
    Clin Nucl Med. 2026 Jun 29. doi: 10.1097/RLU.0000000000006539.
    >> Share

  16. XU Y, Zhang K, Zhang B, Wang X, et al
    Prominent 18F-MFBG Uptake in Brown Adipose Tissue in a Pediatric Patient With Pheochromocytoma.
    Clin Nucl Med. 2026;51:896-897.
    >> Share

  17. NEMATI R, Juweid ME, Jafari E, Jokar N, et al
    Preliminary Evaluation of 225 Ac/ 177 Lu-DOTATATE PRRT in Progressive Meningiomas : Efficacy, Dosimetry, and Imaging Insights.
    Clin Nucl Med. 2026;51:e865-e876.
    >> Share

  18. MIRALAI A, Ghaedian T, Sadra H, Yazdani B, et al
    Discordant 68Ga-FAPI and 18F-FDG Uptake in Reactive Lymph Nodes in a Case of Esophageal Cancer and Systemic Lupus Erythematosus.
    Clin Nucl Med. 2026 May 13. doi: 10.1097/RLU.0000000000006541.
    >> Share

  19. CHEN KC, Chang YM, Su HH, Shen DH, et al
    Could a Bronchogenic Cyst Present as an I-131-avid, 99mTc-Non-Avid Lesion and Mimic Metastatic Thyroid Cancer?
    Clin Nucl Med. 2026 Mar 30. doi: 10.1097/RLU.0000000000006353.
    >> Share

  20. HOU Y, Wang J, Dai Y, Xu Z, et al
    Occult Maxillary Sinus Phosphaturic Mesenchymal Tumor Localized by 68Ga-DOTATATE PET/CT After Repeated Negative Parathyroid Imaging.
    Clin Nucl Med. 2026 Sep 9. doi: 10.1097/RLU.0000000000006696.
    >> Share

  21. ESHGHI A, Phelan N, Stratford R, Palot Manzil FF, et al
    Disproportionately Enlarged Subarachnoid Space Hydrocephalus (DESH) Identified on I-123 Ioflupane SPECT/CT.
    Clin Nucl Med. 2026 Sep 10. doi: 10.1097/RLU.0000000000006705.
    >> Share

  22. RABANI F, Taheri F, Torghabeh AE, Kamali H, et al
    Utility of 99mTc-FAPI-46 SPECT/CT in Restaging Hepatocellular Carcinoma: A Case Report.
    Clin Nucl Med. 2026 Sep 9. doi: 10.1097/RLU.0000000000006680.
    >> Share

  23. AKKUS GUNDUZ P, Cidemal M, Gokcay Canpolat A, Soydal C, et al
    Incidental Thyroid Uptake on 18F-FES PET/CT Revealing Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2026 Sep 11. doi: 10.1097/RLU.0000000000006691.
    >> Share

  24. ZENG C, Zheng H, Feng Z, Guan H, et al
    [18F]FDG PET/CT Findings of Primary Uterine Dysgerminoma: A Case Report.
    Clin Nucl Med. 2026 Sep 9. doi: 10.1097/RLU.0000000000006700.
    >> Share

  25. HU W, Li M, Jiang D, Cai X, et al
    Glypican-3-Targeted PET/MR Identifies MRI-Indeterminate Early Hepatocellular Carcinoma in Cirrhosis.
    Clin Nucl Med. 2026 Sep 9. doi: 10.1097/RLU.0000000000006695.
    >> Share

  26. CHEN J, Wang Q
    F-18 FDG PET/CT of Concurrent Cutaneous, Osseous, and Bilateral Breast Metastases From Endometrial Carcinoma.
    Clin Nucl Med. 2026 Sep 9. doi: 10.1097/RLU.0000000000006706.
    >> Share

  27. AASTRUP M, Hansen ESS, Fuglsang K, Bouchelouche K, et al
    Hyperpolarized [1-13C]-Pyruvate MRI Differentiates Benign Fibroma From High-grade Serous Carcinoma.
    Clin Nucl Med. 2026;51:885-887.
    >> Share

  28. MING H, Guo T, Yu H
    Hepatic FDG Avidity From a Migrating Gastric Foreign Body: A PET/CT Pitfall: Erratum.
    Clin Nucl Med. 2026;51:968.
    >> Share

  29. MCLEOD A, Hesse S, Badendick M, Henssen D, et al
    False-Positive [(1)(8)F]FET-Uptake in a Developmental Venous Anomaly: A Diagnostic Pitfall.
    Clin Nucl Med. 2026;51:e970-e971.
    >> Share

  30. BAGASARIYA R, Sonavane S, Basu S
    Tuberculosis Mimicking Tumor Progression on Dual-tracer 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Neuroendocrine Tumor of Unknown Primary: A Potential Imaging Pitfall in Neuroendocrine Tumor Surveillance.
    Clin Nucl Med. 2026;51:e944-e946.
    >> Share

  31. DIVBAND G, Amini H, Saeidi Saedi H, Shahvarani SA, et al
    Multimodal Management of Advanced Metastatic Prostate Cancer: Excellent Response Following Resection of Brain Metastasis and 177Lu-PSMA Therapy.
    Clin Nucl Med. 2026;51:e917-e919.
    >> Share

  32. AHMADI M, Samadi MH, Saber Tanha A, Askari E, et al
    Detected Huge Urinoma With 99mTc-PSMA Activity on Initial Prostate Cancer Staging.
    Clin Nucl Med. 2026;51:e898-e900.
    >> Share

  33. LEI Q, Huang L, Zhou L, Xiang K, et al
    Extraskeletal Ewing Sarcoma Involving the Abdominal Cavity and Retroperitoneum on 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT.
    Clin Nucl Med. 2026;51:959-960.
    >> Share

  34. MOU L, Yao Z, Zheng W, Zhang C, et al
    Combined 177Lu-FAP-2286 Therapy and Chemotherapy in Extraskeletal Ewing Sarcoma With Multiple Metastases.
    Clin Nucl Med. 2026;51:952-954.
    >> Share

  35. ZHOU L, Zhang S, Liu W, Lei Q, et al
    A Case of FDG-Avid but FAPI-Negative Peritoneal Metastatic Gastrointestinal Stromal Tumor.
    Clin Nucl Med. 2026;51:950-951.
    >> Share

  36. TAKAHASHI K, Sasaki D, Uemura S, Sakaue T, et al
    Discordance of 99mTc-PYP Uptake in the Myocardium and Breast Both Before and After Treatment in Transthyretin Cardiac Amyloidosis.
    Clin Nucl Med. 2026;51:908-910.
    >> Share

  37. MOIN A, Solnes L, Rowe SP, Frankl J, et al
    Large Calyceal Diverticulum Mimicking a Solid Renal Mass in a Patient Undergoing 68Ga-DOTATATE PET/CT.
    Clin Nucl Med. 2026 Sep 8. doi: 10.1097/RLU.0000000000006684.
    >> Share


    J Cereb Blood Flow Metab

  38. KHATTAR N, Matuskey D, Gallezot JD, Naganawa M, et al
    Optimized reference region and the effect on test-retest reliability and sensitivity to differences between Parkinson's disease and control groups with [(11)C]UCB-J.
    J Cereb Blood Flow Metab. 2026;46:2302-2311.
    >> Share

  39. VANDERLINDEN G, Carron C, Van Opstal J, Cohilis M, et al
    Quantification of (18)F-SynVesT-1 binding in healthy aging and head-to-head comparison with (11)C-UCB-J.
    J Cereb Blood Flow Metab. 2026;46:2426-2435.
    >> Share


    J Nucl Cardiol

  40. LANE DUVALL W, Skali H, Aggarwal NR, Boczar KE, et al
    2026 ASNC guideline for stress testing in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) myocardial perfusion imaging.
    J Nucl Cardiol. 2026 Sep 8:102970. doi: 10.1016/j.nuclcard.2026.102970.
    >> Share


    J Nucl Med

  41. TOLMEIJER SH, Kwan EM, Gafita A, Hamid AA, et al
    Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
    J Nucl Med. 2026 Sep 10:jnumed.126.273266. doi: 10.2967/jnumed.126.273266.
    >> Share

  42. ASPROMONTE SM, Feinberg TY, Gavane S, Parker C, et al
    Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma.
    J Nucl Med. 2026 Sep 10:jnumed.126.272770. doi: 10.2967/jnumed.126.272770.
    >> Share

  43. CHIOTIS K, Windon CC, Siegel BA, Apgar C, et al
    Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study.
    J Nucl Med. 2026 Sep 10:jnumed.126.272571. doi: 10.2967/jnumed.126.272571.
    >> Share

  44. WANG D, Du L, Wang Y, Song J, et al
    Diagnostic Performance of [(68)Ga]Ga-DPI-4452 PET/CT in Patients with Clear Cell Renal Cell Carcinoma: A Prospective Trial.
    J Nucl Med. 2026 Sep 10:jnumed.126.272990. doi: 10.2967/jnumed.126.272990.
    >> Share

  45. EDMONDS CE, Surti S
    Is Dedicated Breast PET Really Happening?
    J Nucl Med. 2026 Sep 10:jnumed.125.271157. doi: 10.2967/jnumed.125.271157.
    >> Share

  46. LINDENBERG L, Huang E, Ulaner GA, Patel KR, et al
    Quantitative Thresholds on (18)F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation.
    J Nucl Med. 2026 Sep 10:jnumed.126.272271. doi: 10.2967/jnumed.126.272271.
    >> Share

  47. VAN STEE CP, van Leer B, Pinto Pereira J, Tamasi K, et al
    Visualizing Persistent Inflammation and Occult Infections in Nonrecovering ICU Patients with [(18)F]FDG PET/CT: VIPER Study Protocol.
    J Nucl Med. 2026 Sep 10:jnumed.126.272736. doi: 10.2967/jnumed.126.272736.
    >> Share

  48. IIDA H, Larsson HBW, Law I, Fukuda H, et al
    Regional Blood Flow Assessment in Total-Body Organs with Improved Temporal Resolution Using Long-Axial-Field-of-View PET.
    J Nucl Med. 2026 Sep 10:jnumed.125.270159. doi: 10.2967/jnumed.125.270159.
    >> Share

  49. CIVAN C, Fendler WP, Kuper A, Bodei L, et al
    The State of the Art of Theranostics and Its Future.
    J Nucl Med. 2026;67.
    >> Share

  50. GOTTHARDT M, Jadvar H, Mankoff D
    The Case for Nuclear Oncology Specialization: Training Physicians for Radiopharmaceutical Therapy.
    J Nucl Med. 2026;67.
    >> Share

  51. WANG Y, McKenzie J, Sandhu S
    Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.
    J Nucl Med. 2026;67.
    >> Share

  52. WAHL RL, Dewaraja YK
    Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.
    J Nucl Med. 2026;67.
    >> Share

  53. ABT ER, Radu CG, Czernin J, Mona CE, et al
    Radiopharmaceutical Therapy-Linked Tumor Resistance: Immune Evasion, Nonimmune Mechanisms, and Immunometabolic Vulnerabilities.
    J Nucl Med. 2026;67.
    >> Share

  54. HADASCHIK B, Sartor O
    Are Urooncologists Onboard?
    J Nucl Med. 2026;67.
    >> Share

  55. NDLOVU H, Lawal IO, Moholisa RR, Kabunda J, et al
    Lesion Detection and Uptake Patterns of [(18)F]F-ATD001 PET/CT and [(18)F]FDG PET/CT in Triple-Negative Breast Cancer.
    J Nucl Med. 2026 Sep 10:jnumed.125.271973. doi: 10.2967/jnumed.125.271973.
    >> Share


    Lancet Neurol

  56. BENZINGER TLS, Cogswell PM, Arani A, Chaney AM, et al
    Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.
    Lancet Neurol. 2026;25:939-951.
    >> Share


    Nucl Med Commun

  57. ERDOGAN EB, Yildiz Y, Ramadan E, Toluk O, et al
    Predictive value of metabolic and tumor dissemination parameters in diffuse large B-cell lymphoma: can relapse be predicted despite adequate interim PET response?
    Nucl Med Commun. 2026 Sep 10. doi: 10.1097/MNM.0000000000002238.
    >> Share

  58. OZTURK I, Yaran SG, Hancerli O, Kaya EM, et al
    Prognostic impact of risk organ involvement and metabolic parameters assessed by staging 18F-FDG PET/CT in pediatric Langerhans cell histiocytosis.
    Nucl Med Commun. 2026 Sep 10. doi: 10.1097/MNM.0000000000002242.
    >> Share

  59. YAMAGUCHI H
    Workforce fragility in hospital-based radiopharmaceutical production: implications for nuclear medicine practice.
    Nucl Med Commun. 2026;47:1218-1219.
    >> Share

  60. MALIK P, Saraswat D, Aggarwal P, Singh H, et al
    The utility of 18F-fluorodeoxyglucose PET/computed tomography in relapsing polychondritis: a systematic review and meta-analysis.
    Nucl Med Commun. 2026;47:1117-1125.
    >> Share

  61. LEE JH, Choi J, Park S, Lee G, et al
    Relationship between prostatic fluorodeoxyglucose uptake, prostatic calcifications, and urologic symptom questionnaires.
    Nucl Med Commun. 2026;47:1148-1154.
    >> Share


    Phys Med Biol

  62. DONG Z, Jin X, Meng X, Liu W, et al
    Learning-enhanced hybrid planar-SPECT dosimetry for voxel-level Monte Carlo dose estimation in radionuclide therapy.
    Phys Med Biol. 2026 Sep 7. doi: 10.1088/1361-6560.
    >> Share

  63. ZHANG Y, Long Y, Wang H, Rao F, et al
    Structure-guided prior-driven implicit neural representations for time-of-flight PET image reconstruction.
    Phys Med Biol. 2026 Sep 7. doi: 10.1088/1361-6560.
    >> Share

  64. TANG C, Van Laere K, Koole M
    PKiNN: a PET kinetics-informed neural network for dynamic PET kinetic modeling.
    Phys Med Biol. 2026 Sep 7. doi: 10.1088/1361-6560.
    >> Share

  65. JABBARPOUR A, Siraj G, Kaviani S, Lang J, et al
    Artificial count enhancement in lung scintigraphy for acquisition acceleration and pseudo-planar generation.
    Phys Med Biol. 2026;71.
    >> Share

  66. KRZEMIEN W, Bala M, Dulski K, Zdeb W, et al
    A Monte Carlo positronium decay source model with multiple annihilation channels in GATE.
    Phys Med Biol. 2026;71.
    >> Share


    PLoS One

  67. CHIBA N, Abe Y, Kojima H, Suda R, et al
    The coefficient of variation of CT values for predicting lymph node metastasis in extrahepatic cholangiocarcinoma.
    PLoS One. 2026;21:e0357578.
    >> Share


    Semin Nucl Med

  68. ERYILMAZ Y, Gezmis E, Uner A, Akin S, et al
    MALT lymphoma with synchronous lacrimal gland and gastric involvement on (18)F-FDG PET/CT: a rare presentation.
    Semin Nucl Med. 2026 Sep 12:S0001-2998(26)00180.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016